NCT00884832View on ClinicalTrials.gov

A Placebo-Controlled Study of Clonidine for Fecal Incontinence.

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Fecal Incontinence
Interventions
DRUG

Clonidine

Subjects randomized to Clonidine will take 0.1 mg of the medication orally twice a day for a total of 4 weeks.

DRUG

Placebo

Subjects randomized to the placebo group will also take 0.1 mg of matching placebo pills orally twice a day for a total of 4 weeks.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Mayo Clinic

OTHER